saxenda glp-1 diabetes market impact Glucagon-like Peptide-1 (GLP-1) Agonists Size and Companies Oral GLP-1 Market to Rise

What happens if I stop the medication

MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study

Reasons for shortages: Very high demand for weight loss treatment Limited production Priority given to diabetes patients first Countries reporting shortages in 2025: United Kingdom Germany France Spain Italy Denmark Sweden To help manage this: Plan your prescription refills ahead of time Be flexible about the brand or dose if needed Be aware that temporary supply issues may occur

First, you must have a Medicare Part D prescription drug plan or a Medicare Advantage plan with prescription drug coverage

Anyone without medical screening should avoid it